Bone Biologics Corp Stock Price Prediction

BBLG Stock  USD 0.83  0.02  2.35%   
As of 16th of March 2025, the relative strength index (RSI) of Bone Biologics' share price is approaching 30 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Bone Biologics, making its price go up or down.

Momentum 30

 Sell Stretched

 
Oversold
 
Overbought
The successful prediction of Bone Biologics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Bone Biologics and does not consider all of the tangible or intangible factors available from Bone Biologics' fundamental data. We analyze noise-free headlines and recent hype associated with Bone Biologics Corp, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Bone Biologics' stock price prediction:
EPS Estimate Next Quarter
(0.48)
EPS Estimate Current Year
(2.30)
EPS Estimate Next Year
(2.33)
Wall Street Target Price
16.5
EPS Estimate Current Quarter
(0.65)
Using Bone Biologics hype-based prediction, you can estimate the value of Bone Biologics Corp from the perspective of Bone Biologics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bone Biologics to buy its stock at a price that has no basis in reality. In that case, they are not buying Bone because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Bone Biologics after-hype prediction price

    
  USD 0.83  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Bone Biologics Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.7510.0515.04
Details
1 Analysts
Consensus
LowTargetHigh
34.3537.7541.90
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Bone Biologics After-Hype Price Prediction Density Analysis

As far as predicting the price of Bone Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bone Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Bone Biologics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Bone Biologics Estimiated After-Hype Price Volatility

In the context of predicting Bone Biologics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bone Biologics' historical news coverage. Bone Biologics' after-hype downside and upside margins for the prediction period are 0.04 and 5.82, respectively. We have considered Bone Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.83
0.83
After-hype Price
5.82
Upside
Bone Biologics is slightly risky at this time. Analysis and calculation of next after-hype price of Bone Biologics Corp is based on 3 months time horizon.

Bone Biologics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Bone Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bone Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bone Biologics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.38 
4.99
 0.00  
  0.03 
2 Events / Month
7 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.83
0.83
0.00 
49,900  
Notes

Bone Biologics Hype Timeline

Bone Biologics Corp is currently traded for 0.83. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.03. Bone is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at -0.38%. %. The volatility of related hype on Bone Biologics is about 6074.78%, with the expected price after the next announcement by competition of 0.80. The company has price-to-book (P/B) ratio of 0.78. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bone Biologics Corp recorded a loss per share of 4.83. The entity last dividend was issued on the 24th of July 2018. The firm had 1:8 split on the 20th of December 2023. Given the investment horizon of 90 days the next expected press release will be in a few days.
Check out Bone Biologics Basic Forecasting Models to cross-verify your projections.

Bone Biologics Related Hype Analysis

Having access to credible news sources related to Bone Biologics' direct competition is more important than ever and may enhance your ability to predict Bone Biologics' future price movements. Getting to know how Bone Biologics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bone Biologics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
BJDXBluejay Diagnostics 0.22 2 per month 6.89  0.04  12.20 (12.80) 42.86 
TLISTalis Biomedical Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NUWENuwellis(0.06)6 per month 0.00  0.02  8.11 (6.92) 23.16 
HSCSHeart Test Laboratories(0.02)3 per month 0.00 (0.1) 6.41 (6.56) 19.85 
TIVCTivic Health Systems(0.83)5 per month 7.56  0.06  7.76 (13.84) 221.76 
VVOSVivos Therapeutics 0.05 5 per month 0.00 (0.01) 10.55 (10.34) 28.71 
RPIDRapid Micro Biosystems 0.42 9 per month 5.40  0.20  21.64 (10.00) 47.40 
INVOINVO Old 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
TNONTenon Medical(0.08)4 per month 0.00 (0.16) 5.52 (6.31) 47.29 
MOTSMotus GI Holdings 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NAOVNanoVibronix(0.73)6 per month 0.00 (0.13) 14.26 (16.06) 85.95 
SINTSINTX Technologies 0.13 4 per month 6.25  0.04  10.63 (12.39) 90.56 
RSLSReShape Lifesciences(0.25)6 per month 0.00 (0.25) 6.50 (15.44) 64.76 
RMEDRA Medical Systems 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Bone Biologics Additional Predictive Modules

Most predictive techniques to examine Bone price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bone using various technical indicators. When you analyze Bone charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Bone Biologics Predictive Indicators

The successful prediction of Bone Biologics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bone Biologics Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bone Biologics based on analysis of Bone Biologics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bone Biologics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bone Biologics's related companies.
 2024 2025 (projected)
Payables Turnover0.0013410.001274
Days Of Inventory On Hand368.2327.29

Story Coverage note for Bone Biologics

The number of cover stories for Bone Biologics depends on current market conditions and Bone Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bone Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bone Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Bone Biologics Short Properties

Bone Biologics' future price predictability will typically decrease when Bone Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bone Biologics Corp often depends not only on the future outlook of the potential Bone Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bone Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding1.5 M
Cash And Short Term Investments3.3 M

Complementary Tools for Bone Stock analysis

When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data